Name: UMIN ID:
Unique ID issued by UMIN | UMIN000001875 |
---|---|
Receipt number | R000002255 |
Scientific Title | Phase II clinical trial of personalized peptide vaccination for malignant brain tumor patients |
Date of disclosure of the study information | 2009/04/13 |
Last modified on | 2019/10/30 13:05:07 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2009/04/12 10:59:11 | ||
2 | Update | 2011/09/26 11:29:14 | UMIN ID1 |
|
3 | Update | 2011/09/28 10:33:01 | Recruitment status |
|
4 | Update | 2011/11/04 13:55:56 | Name of person sending information Name of person sending information Organization Division name Division name Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
5 | Update | 2014/07/07 15:53:00 | Email Institute Institute Organization Organization Category of Funding Organization Nationality of Funding Organization Nationality of Funding Organization |
|
6 | Update | 2014/12/12 10:22:16 | Key secondary outcomes |
|
7 | Update | 2014/12/12 10:24:06 | Interventions/Control_1 Key inclusion criteria Key inclusion criteria |
|
8 | Update | 2019/01/07 10:45:49 | Recruitment status |
|
9 | Update | 2019/10/30 13:05:07 | Recruitment status Date of IRB |